Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Perforin-independent rejection of transplanted human stem cells.

Kaiser S, Kägi D, Ihorst G, Kapp U.

Clin Exp Immunol. 2006 Aug;145(2):332-8.

3.

Homeostatic regulation of CD8+ T cells by perforin.

Kägi D, Odermatt B, Mak TW.

Eur J Immunol. 1999 Oct;29(10):3262-72.

4.

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells.

Kapp U, Yeh WC, Patterson B, Elia AJ, Kägi D, Ho A, Hessel A, Tipsword M, Williams A, Mirtsos C, Itie A, Moyle M, Mak TW.

J Exp Med. 1999 Jun 21;189(12):1939-46.

5.

TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.

Kägi D, Ho A, Odermatt B, Zakarian A, Ohashi PS, Mak TW.

J Immunol. 1999 Apr 15;162(8):4598-605.

6.

Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.

Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F, Hahne M, Kägi D, Kaiserlian D, Nicolas JF.

J Exp Med. 1999 Mar 1;189(5):779-86.

7.

Differential requirement for caspase 9 in apoptotic pathways in vivo.

Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW.

Cell. 1998 Aug 7;94(3):339-52.

8.

Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.

Binder D, van den Broek MF, Kägi D, Bluethmann H, Fehr J, Hengartner H, Zinkernagel RM.

J Exp Med. 1998 Jun 1;187(11):1903-20.

9.

Effector pathways of natural killer cells.

Van den Broek MF, Kägi D, Hengartner H.

Curr Top Microbiol Immunol. 1998;230:123-31. Review. No abstract available.

PMID:
9586354
10.

Theiler's virus infection of perforin-deficient mice.

Rossi CP, McAllister A, Tanguy M, Kägi D, Brahic M.

J Virol. 1998 May;72(5):4515-9.

11.

Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.

Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kägi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW.

Genes Dev. 1998 Mar 15;12(6):806-19.

12.

Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.

Bachmann MF, Ohteki T, Faienza KM, Zakarian A, Kägi D, Speiser DE, Ohashi PS.

J Immunol. 1997 Nov 1;159(9):4165-70.

PMID:
9379009
13.

Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.

Kägi D, Odermatt B, Seiler P, Zinkernagel RM, Mak TW, Hengartner H.

J Exp Med. 1997 Oct 6;186(7):989-97.

14.
15.

Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity.

Sad S, Krishnan L, Bleackley RC, Kägi D, Hengartner H, Mosmann TR.

Eur J Immunol. 1997 Apr;27(4):914-22.

PMID:
9130644
16.

Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin.

Tang Y, Hügin AW, Giese NA, Gabriele L, Chattopadhyay SK, Fredrickson TN, Kägi D, Hartley JW, Morse HC 3rd.

J Virol. 1997 Mar;71(3):1808-13.

17.

Differentiation and functions of T cell subsets.

Mosmann TR, Li L, Hengartner H, Kagi D, Fu W, Sad S.

Ciba Found Symp. 1997;204:148-54; discussion 154-8. Review.

PMID:
9107418
18.

The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo.

Duncan GS, Mittrücker HW, Kägi D, Matsuyama T, Mak TW.

J Exp Med. 1996 Nov 1;184(5):2043-8.

19.

Decreased tumor surveillance in perforin-deficient mice.

van den Broek ME, Kägi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, Melief CJ, Zinkernagel RM, Hengartner H.

J Exp Med. 1996 Nov 1;184(5):1781-90.

20.
21.
22.

Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity.

Kägi D, Odermatt B, Ohashi PS, Zinkernagel RM, Hengartner H.

J Exp Med. 1996 May 1;183(5):2143-52.

23.

Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo.

Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H.

Annu Rev Immunol. 1996;14:207-32. Review.

PMID:
8717513
24.

Perforin dependence of natural killer cell-mediated tumor control in vivo.

van den Broek MF, Kägi D, Zinkernagel RM, Hengartner H.

Eur J Immunol. 1995 Dec;25(12):3514-6.

PMID:
8566046
25.

The role of perforin-expression by granular metrial gland cells in pregnancy.

Stallmach T, Ehrenstein T, Isenmann S, Müller C, Hengartner H, Kägi D.

Eur J Immunol. 1995 Dec;25(12):3342-8.

PMID:
8566021
26.

The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses.

Kägi D, Seiler P, Pavlovic J, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H.

Eur J Immunol. 1995 Dec;25(12):3256-62.

PMID:
8566009
27.

Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance.

Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H.

Immunol Rev. 1995 Aug;146:95-115. Review. No abstract available.

PMID:
7493763
28.

Pathways of tumour cell killing by activated macrophages: both tumour cell membrane and nucleus can be the primary target.

Keller R, Keist R, Groscurth P, Hahn S, Stalder T, Schlegel J, Kägi D, Joller P, Nagata S, Erb P.

Cell Death Differ. 1995 Apr;2(2):141-50.

PMID:
17180076
29.

Acute rejection of vascular heart allografts by perforin-deficient mice.

Schulz M, Schuurman HJ, Joergensen J, Steiner C, Meerloo T, Kägi D, Hengartner H, Zinkernagel RM, Schreier MH, Bürki K, et al.

Eur J Immunol. 1995 Feb;25(2):474-80.

PMID:
7533086
30.

CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity.

Kägi D, Ledermann B, Bürki K, Hengartner H, Zinkernagel RM.

Eur J Immunol. 1994 Dec;24(12):3068-72.

PMID:
7805735
31.

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P.

Science. 1994 Jul 22;265(5171):528-30.

PMID:
7518614
32.

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.

Kägi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H.

Nature. 1994 May 5;369(6475):31-7.

PMID:
8164737
33.

Morphologic analysis of human lymphokine-activated killer (LAK) cells.

Groscurth P, Diener S, Stahel R, Jost L, Kägi D, Hengartner H.

Int J Cancer. 1990 Apr 15;45(4):694-704.

PMID:
2157676
34.

Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus.

Müller C, Kägi D, Aebischer T, Odermatt B, Held W, Podack ER, Zinkernagel RM, Hengartner H.

Eur J Immunol. 1989 Jul;19(7):1253-9.

PMID:
2668013
35.

[Nursing care of patients with a kidney transplantation].

Kägi D.

Z Krankenpfl. 1966 Nov;59(11):689-95. German. No abstract available.

PMID:
5331977

Supplemental Content

Support Center